CORDIS - Risultati della ricerca dell’UE
CORDIS

NOVA Institute for Medical Systems Biology

Descrizione del progetto

Far progredire la medicina di precisione in Portogallo

Le malattie croniche sono sempre più diffuse e mettono a dura prova la sostenibilità dei sistemi sanitari di tutto il mondo. Per affrontare questi problemi, è cresciuta l’attenzione per la prevenzione delle malattie, la consapevolezza e la medicina di precisione. Finanziato dal programma ORIZZONTE, il progetto NIMSB sosterrà la creazione di un centro di eccellenza presso il NOVA Institute for Medical Systems Biology (NIMSB) di Lisbona. L’obiettivo è quello di integrare analisi cellulari avanzate, approcci computazionali e dati multi-omici per la comprensione delle malattie croniche e lo sviluppo di nuove terapie. Ricercatori e medici collaboreranno per sviluppare modelli quantitativi e implementare soluzioni di medicina di precisione.

Obiettivo

The rise of chronic diseases is shaping health policy priorities worldwide. As the population ages, these conditions affect increasing portions of society and are more difficult to manage, causing suffering in patients and their families for many years. Such increasing prevalence is a threat to the sustainability of healthcare systems. Thus, an increasing focus has been put on disease prevention and awareness, as well as on precision medicine. This project will create a new Centre of Excellence, NOVA Institute for Medical Systems Biology (NIMSB), which will use the most advanced cell analytics and experimental in vitro systems, combined with computational approaches to understand and fight chronic diseases. The core of the project will be the integration of multi-omics data from single cells from patient biopsies and derived organoids, bioinformatics and artificial intelligence, cell and molecular biology, and relevant animal model studies, to develop quantitative models that can inform on mechanisms of disease progression. Researchers and clinicians will collaborate to use this knowledge to implement novel precision medicine solutions, aiming to intercept diseases before symptoms develop, and also by improving diagnosis, disease course prediction and response to treatment. NIMSB will contribute to clinical practice improvement not only with technology but also by training the next generation of researchers and medical doctors in precision interceptive medicine and digital-transformation technologies. NOVA Medical School of NOVA University is in a unique position to coordinate the project due to its current drive for restructuring, established reputation as a top Medical School in Portugal, and research focus on chronic diseases. The Max Delbrück Center for Molecular Medicine is the best possible advanced partner, as it is a world leader in this research topic and has recently created the Berlin Institute for Medical Systems Biology, which is a model for NIMSB.

Coordinatore

UNIVERSIDADE NOVA DE LISBOA
Contribution nette de l'UE
€ 12 006 000,00
Indirizzo
CAMPUS DE CAMPOLIDE
1099 085 Lisboa
Portogallo

Mostra sulla mappa

Regione
Continente Área Metropolitana de Lisboa Área Metropolitana de Lisboa
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 12 006 000,00

Partecipanti (1)